FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine
FDA (Jan. 03, 2022) – The U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to: Expand the use of a single booster dose to include use in individuals 12 through 15 years of age. Shorten the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 […]